12:00 AM
 | 
Jul 09, 2012
 |  BC Week In Review  |  Company News  |  Deals

ADC Therapeutics, Cancer Research U.K. deal

ADC Therapeutics partnered with the research center's commercial arm Cancer Research Technology Ltd. to develop antibody-drug conjugates (ADCs) to treat cancer. The partners will use undisclosed antibodies and peptides from the...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >